The American journal of emergency medicine
-
Timely identification and treatment of intracranial hematomas in patients with brain injury is essential for successful treatment. This study evaluates Infra-scanner as a handy medical screening tool for diagnosing, on-site, cerebral hematomas in patients with head injury. ⋯ This study shows that Infra-scanner is useful in initial examination and screening of patients with head injury and can be used as an adjunct to a CT scan or when not available and may allow earlier treatment which reduce the secondary damage to the hematoma.
-
Gender disparities continue to exist in emergency medicine (EM) despite increasing percentages of women in medical school and residencies. Prior studies in other male dominated industries have shown using masculine or feminine-coded language in job advertisements affects the proportion of male versus female applicants who choose to apply for those jobs. The goal of this study was to determine if gender-coding exists in EM job advertisements, and to see if there were differences between academic vs. non-academic jobs or administrative vs. non-administrative jobs. ⋯ Job advertisements for EM physicians tend to contain more masculine-coded language. Almost all job advertisements for emergency medicine physicians in this study contained at least one gender-coded word. Further studies could explore whether changing the language of job advertisements in EM has an impact on the proportion of women who choose to apply to EM jobs.
-
Violence and aggressive behaviors among youth are a leading cause of Emergency Department (ED) mental health (MH) encounters. A consistent method is needed for public health research, to identify ED encounters associated with aggression. The aim of this study was to develop such a screening procedure. ⋯ This paper presents a screening method for identifying ED encounters related to aggression. A replication study will be necessary to validate the method prior to applying to large claims data. If validated, it will support future research on this important population.
-
There is limited information directly comparing andexanet alfa (AA) versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage (ICH) on apixaban or rivaroxaban. ⋯ This study found no significant differences in good or excellent ICH hemostasis within 24-h or new thrombotic events within 14-days in a cohort given AA or 4F-PCC for ICH while on apixaban or rivaroxaban. However, this single-center analysis is underpowered due to sample size constraints, therefore further high-quality research comparing AA safety and effectiveness versus 4F-PCC is needed.